[WEBINAR] LED phototherapy in skin cancer, general dermatology and aesthetic medicine

LED

Do you use LED phototherapy in your practice, or do you wish to utilise its full potential in treating a range of skin concerns? In this webinar, Skin Cancer and Aesthetic Medicine Doctor Di King shares how light emitting diode (LED) can be used to treat a range of common dermatological presentations, including acne, superficial skin lesions, and wound healing. Continue reading “[WEBINAR] LED phototherapy in skin cancer, general dermatology and aesthetic medicine”

[2 min read] Surgery vs curettage & imiquimod for nodular BCC

nodular BCC

Nodular basal cell carcinoma (BCC) is most often treated with surgical excision. However, interest is increasing in minimally invasive treatments for these low-risk skin cancers. A new study reviewed the effectiveness of surgical excision compared with curettage and imiquimod cream in treating nodular BCC. Continue reading “[2 min read] Surgery vs curettage & imiquimod for nodular BCC”

[2 min read] Field treatments for actinic keratosis | Prof David Wilkinson

actinic keratosis

Treating actinic keratosis is very common in general practice, and especially so in primary care skin cancer medicine. Many patients require treatment of both individual lesions (for example, by cryotherapy) and of the whole field that is affected (for example, the whole face, using a topical treatment, or a field treatment more generally). Continue reading “[2 min read] Field treatments for actinic keratosis | Prof David Wilkinson”

[3 min read] Photodynamic therapy for Bowen’s disease

photodynamic

How effective and safe is photodynamic therapy in treating Bowen’s disease? Bowen’s disease is an intraepidermal squamous cell carcinoma (SCC). There are several alternatives for treatment of Bowen’s disease, including photodynamic therapy. A new study investigated the efficacy and safety of photodynamic therapy in treating the skin condition. Continue reading “[3 min read] Photodynamic therapy for Bowen’s disease”

[6 min read] Can we predict melanoma immunotherapy success?

cells immunotherapy melanoma

New research suggests that the success of immunotherapy for melanoma can be predicted before treatment begins. A common issue with immunotherapies is that a drug that works well in many patients may have little effect in other patients with the same cancer type. But researchers have now identified new markers that can help predict which patients will have a better chance of responding positively to immunotherapy treatments. Continue reading “[6 min read] Can we predict melanoma immunotherapy success?”

[2 min read] New cryotherapy guidelines | Prof David Wilkinson

cryotherapy

The new Non-Melanoma Skin Cancer Guidelines have been released. A PDF summary of the key recommendations is helpfully provided, which is well worth a read and important to become familiar with. Continue reading “[2 min read] New cryotherapy guidelines | Prof David Wilkinson”

[4 min read] Blocking key regulator could treat non-melanoma skin cancers

The outer layer of the skin completely replaces itself every two to four weeks, but when this process is blocked, cancer can grow. A new study from researchers at the University of Pennsylvania has now identified a key regulator of that block known as LSD1, as well as a way to genetically influence the skin to grow in a way that prevents this block from happening. Continue reading “[4 min read] Blocking key regulator could treat non-melanoma skin cancers”

[4 min read] Personalised nanovaccines for melanoma

A study has found that personalised nanovaccines are safe, well tolerated, and have an effect in melanoma.
Porous silicon and adenovirus-based bio-hybrid nanovaccines were developed in a study carried out at the University of Helsinki, providing new insights on the structure and efficacy of these systems as therapeutic cancer nanovaccines.

Continue reading “[4 min read] Personalised nanovaccines for melanoma”

[WEBINAR] Benefits and review of Picato for solar keratosis

Picato

In this webinar, Dr Tony Dicker reviews Picato® and its benefits for the treatment of solar keratosis. Dr Dicker discusses the use of lesion-directed therapies in a clinical setting, including the efficacy and skin reactions of Picato®. Continue reading “[WEBINAR] Benefits and review of Picato for solar keratosis”

[3 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [August 2019]

skin cancer update

In this month’s skin cancer update video, Professor Giuseppe Argenziano discusses how a new therapeutic agent, cemiplimab, might be used in combination with radiotherapy to treat advanced squamous cell carcinoma. Continue reading “[3 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [August 2019]”